Viva Biotech Holdings engages in the discovery, development, and manufacturing of clinical drugs. It operates through Drug Discovery, and Contract Development Manufacture Organisation (“CDMO”) and Commercialization segments. The Drug Discovery segment involves in structure-based drug discovery services to biotechnology and pharmaceutical customers for their pre-clinical stage innovative drug development. The Contract Development Manufacture Organisation (“CDMO”) and Commercialization segment consists of contract development and manufacturing services for small molecule APIs and intermediates and trading of APIs, intermediates and formulations. The company was founded by Feng Mao Hua, Chen Cheney Mao and Ying Wu on August 27, 2008 and is headquartered in Shanghai, China.